Kim Stanley
Overview
Explore the profile of Kim Stanley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mendelsohn S, Mulenga H, Tameris M, Moloantoa T, Malherbe S, Katona A, et al.
medRxiv
. 2025 Feb;
PMID: 39974049
Background: More than half of tuberculosis (TB) detected by community prevalence surveys is classified as asymptomatic. We evaluated yield of symptom and chest radiograph (CXR) screening of TB-exposed household contacts...
2.
Muwanga V, Mendelsohn S, Leukes V, Stanley K, Mbandi S, Erasmus M, et al.
Eur Respir J
. 2024 Jul;
64(2).
PMID: 38964778
Background: Multiple host blood transcriptional signatures have been developed as non-sputum triage tests for tuberculosis (TB). We aimed to compare the diagnostic performance of 20 blood transcriptomic TB signatures for...
3.
Mutavhatsindi H, Manyelo C, Snyders C, van Rensburg I, Kidd M, Stanley K, et al.
J Infect
. 2024 May;
89(1):106173.
PMID: 38734311
Background: There is a need for new tools for monitoring of the response to TB treatment. Such tools may allow for tailored treatment regimens, and stratify patients initiating TB treatment...
4.
Nelson G, Narayanan N, Onguti S, Stanley K, Newland J, Doernberg S
Infect Dis Clin North Am
. 2023 Sep;
37(4):683-714.
PMID: 37735012
Antimicrobial Stewardship Programs (ASP) improve individual patient outcomes and clinical care processes while reducing antimicrobial-associated adverse events, optimizing operational priorities, and providing institutional cost savings. ASP composition, resources required, and...
5.
Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity
Eckold C, van Doorn C, Ruslami R, Ronacher K, Riza A, van Veen S, et al.
Clin Transl Med
. 2023 Aug;
13(9):e1375.
PMID: 37649224
Background: People with diabetes are more likely to develop tuberculosis (TB) and to have poor TB-treatment outcomes than those without. We previously showed that blood transcriptomes in people with TB-diabetes...
6.
Richardson T, Smith B, Malherbe S, Shaw J, Noor F, MacDonald C, et al.
BMC Infect Dis
. 2023 Jul;
23(1):447.
PMID: 37400753
Background: To improve tuberculosis (TB) diagnosis, the World Health Organisation (WHO) has called for a non-sputum based triage test to focus TB testing on people with a high likelihood of...
7.
Chu V, Nafees S, Waltari E, McNeil N, Caughell C, Sanchez-Guerrero E, et al.
Infect Control Hosp Epidemiol
. 2023 Jun;
44(12):2059-2061.
PMID: 37308466
Two independent temporal-spatial clusters of hospital-onset infections were evaluated using whole-genome sequencing (WGS). Phylogenetic analysis confirmed that isolates within each cluster were unrelated despite epidemiological suspicion of outbreaks. The ITS1...
8.
van Doorn C, Eckold C, Ronacher K, Ruslami R, van Veen S, Lee J, et al.
EBioMedicine
. 2022 Jul;
82:104173.
PMID: 35841871
Background: Globally, the tuberculosis (TB) treatment success rate is approximately 85%, with treatment failure, relapse and death occurring in a significant proportion of pulmonary TB patients. Treatment success is lower...
9.
Manyelo C, Solomons R, Snyders C, Kidd M, Kooblal Y, Leukes V, et al.
Biomarkers
. 2022 May;
27(6):549-561.
PMID: 35506251
The diagnosis of tuberculous meningitis (TBM) in children is often delayed due to diagnostic difficulties. New tools are urgently needed to improve the diagnosis of the disease in this vulnerable...
10.
Hiemstra A, MacDonald C, van Rensburg I, Stanley K, Maasdorp E, Mc Anda S, et al.
BMC Infect Dis
. 2022 Apr;
22(1):381.
PMID: 35428268
Background: Natural immunity against Mycobacterium tuberculosis exists, and > 90% of those infected remain disease-free. Innate and adaptive immune responses required to mediate such protection against tuberculosis (TB) are, however,...